Subtitles section Play video
RESOURCES
RESOURCES AND
RESOURCES AND AS
RESOURCES AND AS OF
RESOURCES AND AS OF TODAY
RESOURCES AND AS OF TODAY CORONAVIRUS
RESOURCES AND AS OF TODAY CORONAVIRUS HAS
RESOURCES AND AS OF TODAY CORONAVIRUS HAS BEEN
RESOURCES AND AS OF TODAY CORONAVIRUS HAS BEEN TO
RESOURCES AND AS OF TODAY CORONAVIRUS HAS BEEN TO 18
CORONAVIRUS HAS BEEN TO 18
CORONAVIRUS HAS BEEN TO 18 COUNTRIES.
COUNTRIES.
COUNTRIES. GEORGIA4@
COUNTRIES. GEORGIA4@ IS
COUNTRIES. GEORGIA4@ IS A
COUNTRIES. GEORGIA4@ IS A PART
COUNTRIES. GEORGIA4@ IS A PART OF
COUNTRIES. GEORGIA4@ IS A PART OF THE
COUNTRIES. GEORGIA4@ IS A PART OF THE RACE
COUNTRIES. GEORGIA4@ IS A PART OF THE RACEO
GEORGIA4@ IS A PART OF THE RACEO
GEORGIA4@ IS A PART OF THE RACEO DEVELOP
GEORGIA4@ IS A PART OF THE RACEO DEVELOP A
GEORGIA4@ IS A PART OF THE RACEO DEVELOP A VACCINE
GEORGIA4@ IS A PART OF THE RACEO DEVELOP A VACCINE AND
GEORGIA4@ IS A PART OF THE RACEO DEVELOP A VACCINE AND DEKALB
DEVELOP A VACCINE AND DEKALB
DEVELOP A VACCINE AND DEKALB COUNTY
DEVELOP A VACCINE AND DEKALB COUNTY COMPANY
DEVELOP A VACCINE AND DEKALB COUNTY COMPANY BELIEVES
DEVELOP A VACCINE AND DEKALB COUNTY COMPANY BELIEVES IT
DEVELOP A VACCINE AND DEKALB COUNTY COMPANY BELIEVES IT HAS
COUNTY COMPANY BELIEVES IT HAS
COUNTY COMPANY BELIEVES IT HAS AN
COUNTY COMPANY BELIEVES IT HAS AN ADVANTAGE
COUNTY COMPANY BELIEVES IT HAS AN ADVANTAGE BECAUSE
COUNTY COMPANY BELIEVES IT HAS AN ADVANTAGE BECAUSE IT
COUNTY COMPANY BELIEVES IT HAS AN ADVANTAGE BECAUSE IT HAS
AN ADVANTAGE BECAUSE IT HAS
AN ADVANTAGE BECAUSE IT HAS QUITE
AN ADVANTAGE BECAUSE IT HAS QUITE A
AN ADVANTAGE BECAUSE IT HAS QUITE A LONG
AN ADVANTAGE BECAUSE IT HAS QUITE A LONG TRACK
AN ADVANTAGE BECAUSE IT HAS QUITE A LONG TRACK RECORD.
QUITE A LONG TRACK RECORD.
QUITE A LONG TRACK RECORD. >>
QUITE A LONG TRACK RECORD. >> WE
QUITE A LONG TRACK RECORD. >> WE WANTED
QUITE A LONG TRACK RECORD. >> WE WANTED TO
QUITE A LONG TRACK RECORD. >> WE WANTED TO LEARN
QUITE A LONG TRACK RECORD. >> WE WANTED TO LEARN MORE
>> WE WANTED TO LEARN MORE
>> WE WANTED TO LEARN MORE ABOUT
>> WE WANTED TO LEARN MORE ABOUT THE
>> WE WANTED TO LEARN MORE ABOUT THE PROCESS
>> WE WANTED TO LEARN MORE ABOUT THE PROCESS AND
>> WE WANTED TO LEARN MORE ABOUT THE PROCESS AND JOE
>> WE WANTED TO LEARN MORE ABOUT THE PROCESS AND JOE HENKE
ABOUT THE PROCESS AND JOE HENKE
ABOUT THE PROCESS AND JOE HENKE STOPPED
ABOUT THE PROCESS AND JOE HENKE STOPPED BY
ABOUT THE PROCESS AND JOE HENKE STOPPED BY FOR
ABOUT THE PROCESS AND JOE HENKE STOPPED BY FOR A
ABOUT THE PROCESS AND JOE HENKE STOPPED BY FOR A LAB
ABOUT THE PROCESS AND JOE HENKE STOPPED BY FOR A LAB REPORT.
STOPPED BY FOR A LAB REPORT.
STOPPED BY FOR A LAB REPORT. >>
STOPPED BY FOR A LAB REPORT. >> Reporter:
STOPPED BY FOR A LAB REPORT. >> Reporter: CURRENTLY
STOPPED BY FOR A LAB REPORT. >> Reporter: CURRENTLY A
STOPPED BY FOR A LAB REPORT. >> Reporter: CURRENTLY A RISK
>> Reporter: CURRENTLY A RISK
>> Reporter: CURRENTLY A RISK OF
>> Reporter: CURRENTLY A RISK OF VACCINES
>> Reporter: CURRENTLY A RISK OF VACCINES FOR
>> Reporter: CURRENTLY A RISK OF VACCINES FOR THE
>> Reporter: CURRENTLY A RISK OF VACCINES FOR THE VIRUS
>> Reporter: CURRENTLY A RISK OF VACCINES FOR THE VIRUS IS
OF VACCINES FOR THE VIRUS IS
OF VACCINES FOR THE VIRUS IS BEING
OF VACCINES FOR THE VIRUS IS BEING TESTED
OF VACCINES FOR THE VIRUS IS BEING TESTED OR
OF VACCINES FOR THE VIRUS IS BEING TESTED OR READY
OF VACCINES FOR THE VIRUS IS BEING TESTED OR READY TO
OF VACCINES FOR THE VIRUS IS BEING TESTED OR READY TO BE
BEING TESTED OR READY TO BE
BEING TESTED OR READY TO BE TESTED
BEING TESTED OR READY TO BE TESTED AND
BEING TESTED OR READY TO BE TESTED AND SOME4@
BEING TESTED OR READY TO BE TESTED AND SOME4@ ARE
BEING TESTED OR READY TO BE TESTED AND SOME4@ ARE VIRUSES
TESTED AND SOME4@ ARE VIRUSES
TESTED AND SOME4@ ARE VIRUSES SIMILAR
TESTED AND SOME4@ ARE VIRUSES SIMILAR TO
TESTED AND SOME4@ ARE VIRUSES SIMILAR TO CORONAVIRUS
TESTED AND SOME4@ ARE VIRUSES SIMILAR TO CORONAVIRUS WHICH
SIMILAR TO CORONAVIRUS WHICH
SIMILAR TO CORONAVIRUS WHICH COULD
SIMILAR TO CORONAVIRUS WHICH COULD SPEED
SIMILAR TO CORONAVIRUS WHICH COULD SPEED UP
SIMILAR TO CORONAVIRUS WHICH COULD SPEED UP THE
SIMILAR TO CORONAVIRUS WHICH COULD SPEED UP THE PROCESS
SIMILAR TO CORONAVIRUS WHICH COULD SPEED UP THE PROCESS AND
COULD SPEED UP THE PROCESS AND
COULD SPEED UP THE PROCESS AND SOME
COULD SPEED UP THE PROCESS AND SOME WHO
COULD SPEED UP THE PROCESS AND SOME WHO HAS
COULD SPEED UP THE PROCESS AND SOME WHO HAS SIX
COULD SPEED UP THE PROCESS AND SOME WHO HAS SIX EXISTING
SOME WHO HAS SIX EXISTING
SOME WHO HAS SIX EXISTING RELATIONSHIPS
SOME WHO HAS SIX EXISTING RELATIONSHIPS WITH
SOME WHO HAS SIX EXISTING RELATIONSHIPS WITH HEALTH
SOME WHO HAS SIX EXISTING RELATIONSHIPS WITH HEALTH 4@
RELATIONSHIPS WITH HEALTH 4@
RELATIONSHIPS WITH HEALTH 4@ OFFICIALS
RELATIONSHIPS WITH HEALTH 4@ OFFICIALS DOESN'T
RELATIONSHIPS WITH HEALTH 4@ OFFICIALS DOESN'T HURT4@
RELATIONSHIPS WITH HEALTH 4@ OFFICIALS DOESN'T HURT4@ EITHER
OFFICIALS DOESN'T HURT4@ EITHER
OFFICIALS DOESN'T HURT4@ EITHER >>
OFFICIALS DOESN'T HURT4@ EITHER >> Reporter:
OFFICIALS DOESN'T HURT4@ EITHER >> Reporter: SCIENTISTS
OFFICIALS DOESN'T HURT4@ EITHER >> Reporter: SCIENTISTS LIKE
OFFICIALS DOESN'T HURT4@ EITHER >> Reporter: SCIENTISTS LIKE RV
>> Reporter: SCIENTISTS LIKE RV
>> Reporter: SCIENTISTS LIKE RV INFECT
>> Reporter: SCIENTISTS LIKE RV INFECT CELLS
>> Reporter: SCIENTISTS LIKE RV INFECT CELLS IN
>> Reporter: SCIENTISTS LIKE RV INFECT CELLS IN VIRUSES
>> Reporter: SCIENTISTS LIKE RV INFECT CELLS IN VIRUSES THEY
INFECT CELLS IN VIRUSES THEY
INFECT CELLS IN VIRUSES THEY ARE
INFECT CELLS IN VIRUSES THEY ARE SETTING
INFECT CELLS IN VIRUSES THEY ARE SETTING AND
INFECT CELLS IN VIRUSES THEY ARE SETTING AND USE
INFECT CELLS IN VIRUSES THEY ARE SETTING AND USE THEIR
ARE SETTING AND USE THEIR
ARE SETTING AND USE THEIR FINDINGS
ARE SETTING AND USE THEIR FINDINGS AS4@
ARE SETTING AND USE THEIR FINDINGS AS4@ THEY
ARE SETTING AND USE THEIR FINDINGS AS4@ THEY DEVELOP
FINDINGS AS4@ THEY DEVELOP
FINDINGS AS4@ THEY DEVELOP VACCINES.
VACCINES.
VACCINES. THEY
VACCINES. THEY USE
VACCINES. THEY USE AN
VACCINES. THEY USE AN APPROACH
VACCINES. THEY USE AN APPROACH THAT
VACCINES. THEY USE AN APPROACH THAT THE
THEY USE AN APPROACH THAT THE
THEY USE AN APPROACH THAT THE CEO
THEY USE AN APPROACH THAT THE CEO SAYS
THEY USE AN APPROACH THAT THE CEO SAYS IT
THEY USE AN APPROACH THAT THE CEO SAYS IT IS
THEY USE AN APPROACH THAT THE CEO SAYS IT IS EFFICIENT
THEY USE AN APPROACH THAT THE CEO SAYS IT IS EFFICIENT IN
CEO SAYS IT IS EFFICIENT IN
CEO SAYS IT IS EFFICIENT IN CREATING
CEO SAYS IT IS EFFICIENT IN CREATING A
CEO SAYS IT IS EFFICIENT IN CREATING A VACCINE
CEO SAYS IT IS EFFICIENT IN CREATING A VACCINE TO
CEO SAYS IT IS EFFICIENT IN CREATING A VACCINE TO BE
CEO SAYS IT IS EFFICIENT IN CREATING A VACCINE TO BE TESTED
CREATING A VACCINE TO BE TESTED
CREATING A VACCINE TO BE TESTED AND
CREATING A VACCINE TO BE TESTED AND 4@EFFECTIVE
CREATING A VACCINE TO BE TESTED AND 4@EFFECTIVE AS
CREATING A VACCINE TO BE TESTED AND 4@EFFECTIVE AS IT
CREATING A VACCINE TO BE TESTED AND 4@EFFECTIVE AS IT MAKES
CREATING A VACCINE TO BE TESTED AND 4@EFFECTIVE AS IT MAKES A
AND 4@EFFECTIVE AS IT MAKES A
AND 4@EFFECTIVE AS IT MAKES A VACCINE
AND 4@EFFECTIVE AS IT MAKES A VACCINE THAT'S